MFC Co.,Ltd.
About MFC Co.,Ltd.
Certifications
Categories
-
Country/Region:Korea, Republic Of
-
On CPHI since:2022
-
Certificates:3
-
Employees:50 - 99
Company types
Primary activities
Meet us at
CPHI & PMEC China 2026
Shanghai New International Expo Center
16 Jun 2026 - 18 Jun 2026
CPHI Korea 2026
COEX, Seoul, Korea
25 Aug 2026 - 27 Aug 2026
Products from MFC Co.,Ltd. (2)
-
Product Synthesis of APIs
APIs: Pitavastatin Calcium Hydrate, Rosuvastatin Calcium, Donepezil, Clopidogrel Bisulfate, Sarpogrelate Hydrochloride, Erdosteine, Pelubiprofen, (S)-Amlodipine Besylate 2.5 Hydrate, (S)-Pantoprazole Sodium Trihydrate
Intermediates of Statins:
MRV-1, ... -
Product TBFA
High purity target compounds in solid phase (amorphous/crystalline form) rather than oil phase.
Detailed technologies: 1) High-purity synthesis technology
2) Separation and purification technology
3...
MFC Co.,Ltd. Resources (1)
-
Video MFC Co.,Ltd
MFC Co., Ltd., established in 2008, is a manufacturer specializing in APIs and key intermediates, which GMP certified from KMFDS. MFC is continuously developing under quality management through thorough quality control and quality assurance system, and technology management that put best efforts in continuous process improvement and new technology development. MFC's direction and aim are the development of new excellent new APIs and intermediates, CMO/CDMO business in accordance with customer requirements, and Incrementally Modified Drugs (IMD) & New Chemical Entity (NCE) using specialized technologies to go forward as a global pharmaceutical company.

